218. Alport syndrome Clinical trials / Disease details


Clinical trials : 26 Drugs : 33 - (DrugBank : 13) / Drug target genes : 6 - Drug target pathways : 29

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04937907
(ClinicalTrials.gov)
September 8, 202117/6/2021Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)Efficacy and Safety of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)Alport Syndrome, X-LinkedDrug: Hydroxychloroquine Sulfate 100 milligram (mg) Tab;Drug: Benazepril hydrochloride 10 milligram (mg) TabShanghai Children's HospitalNULLRecruiting3 Years18 YearsAll50Phase 2China